Imaging has a limited role in primary screening for most common gynecologic cancers, with transvaginal US most commonly used to screen for endometrial and ovarian cancers in individuals at high risk, albeit without any proven mortality benefits, while symptom- or laboratory test–driven evaluations determine indications for imaging in individuals at average risk.
No takes yet. Share an insight, caveat, or question.
Jha et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: